Episode #44: Exploring the World of Minor Cannabinoids Beyond THC and CBD With Dr. Shane Johnson from Bay Medica

Roots to Risk

Dive into the fascinating world of minor cannabinoids with the Roots to Risk Podcast. Hosts Eric Schneider and Isaac Bock are joined by Dr. Shane Johnson from Bay Medica, a leading figure in the cannabis and cannabinoid space. Dr. Johnson shares insights into the biotech side of the industry, focusing on the development of rare cannabinoids and their potential applications in healthcare and consumer products.

Learn about the groundbreaking work being done at Bay Medica, where a team of experts is using a biotechnology approach to produce pure, plant-identical cannabinoids. Discover the unique effects of cannabinoids like THCV, CBC, and CBT, and how small structural differences can lead to significant variations in their effects.

Explore the future of cannabinoid-based medicine, from FDA-approved drugs to potential treatments for neurodegenerative disorders and cancer. Dr. Johnson discusses the importance of consumer education, quality control, and regulatory reform in advancing the industry and ensuring safe, effective products for all.

Tune in to the Roots to Risk Podcast for an enlightening conversation on the science, business, and potential of minor cannabinoids in the cannabis industry.